Thursday 03 Jul, 2025 12:51 PM
Site map | Locate Us | Login
   BSE SME Valencia India sees chilly check-in on debut    Shakti Pumps India launches QIP with floor price of Rs 965.96/share    NBCC inks MoU with NFDC for redevelopment project under I&B Ministry    NSE SME PRO FX Tech strikes a chord with investors    NSE SME Moving Media Entertainment makes a starry market debut    CSB Bank rises after gross advances jump 32% YoY in Q1 FY26; deposits at Rs 35,990 crore    Delphi World Money Ltd leads gainers in 'B' group    Aster DM Healthcare Ltd leads gainers in 'A' group    Mahindra Finance gains as disbursements grow to Rs 12,800 crore YoY in Jun'25    Tata Power dips after arbitration tribunal partially rules in favour of Kleros    Baazar Style Retail revenue rises 37% in Q1 FY26 to Rs 371 crore    PNB records 12% YoY growth in domestic deposits in Q1    Volumes soar at FSN E-Commerce Ventures Ltd counter    Alembic Pharma inks deal to acquire Utility Therapeutics for $12 million    DMart revenue jumps 16% YoY in Q1 FY26 
Saravan Stocks
       
Company News
Balaxi Pharmaceuticals Ltd
Balaxi Pharmaceuticals consolidated net profit declines 60.56% in the December 2024 quarter
Feb 11,2025   Hrs IST

Net profit of Balaxi Pharmaceuticals declined 60.56% to Rs 5.36 crore in the quarter ended December 2024 as against Rs 13.59 crore during the previous quarter ended December 2023. Sales rose 20.56% to Rs 73.29 crore in the quarter ended December 2024 as against Rs 60.79 crore during the previous quarter ended December 2023.

ParticularsQuarter Ended
Dec. 2024Dec. 2023% Var.
Sales73.2960.79 21
OPM %5.4422.47 -
PBDT6.5513.11 -50
PBT6.0712.63 -52
NP5.3613.59 -61

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Account Closure | RE-KYC | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures | Rights & Obligations-English | (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking | Policy GTC | Policy On Inactive Trading Accounts | Risk Disclosure Hit Count : 42380295
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited